Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Prodia Widyahusada TbkISX:PRDA -0.42%69 5-Year Yield-on-Cost % is 8.52 as of Jul. 16, 2026, which is 81% above its 10-year median of 4.72. GuruFocus rates ISX:PRDA with a GF Score™ of 69/100 and a GF Value™ of Rp3,133.50 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 64 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 81.25% on this metric.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost % or its related term are showing as below:
ISX:PRDA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.11 Med: 4.72 Max: 10.47
Current: 8.52
During the past 13 years, PT Prodia Widyahusada Tbk's highest Yield on Cost was 10.47. The lowest was 2.11. And the median was 4.72.
ISX:PRDA's 5-Year Yield-on-Cost % is ranked better than 81.25% of 64
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.455
vs ISX:PRDA: 8.52
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
PT Prodia Widyahusada Tbk 5-Year Yield-on-Cost % Related Terms
ISX:PRDA vs TMO, DHR, IDXX: 5-Year Yield-on-Cost % Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
PT Prodia Widyahusada Tbk (ISX:PRDA) has a 5-Year Yield-on-Cost % of 8.52 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is 81% above median its historical median of 4.72. Over the past decade, PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost % has ranged from 2.11 to 10.47. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #12 out of 64 companies in the Medical Diagnostics & Research industry, placing it in the top 18.7%.
Is PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost % too high?
PT Prodia Widyahusada Tbk's current 5-Year Yield-on-Cost % of 8.52 is 81% above median its 10-year median of 4.72. Over the past 10 years, this metric has ranged from a low of 2.11 to a high of 10.47. The Medical Diagnostics & Research industry median 5-Year Yield-on-Cost % is 2.46. PT Prodia Widyahusada Tbk's value of 8.52 is 247% above this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #12 out of 64 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's 5-Year Yield-on-Cost % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #12 out of 64 companies for 5-Year Yield-on-Cost %. This places PT Prodia Widyahusada Tbk in the top 19% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.46. PT Prodia Widyahusada Tbk's value of 8.52 is 247% above this benchmark. Historically, PT Prodia Widyahusada Tbk's own 5-Year Yield-on-Cost % has ranged from 2.11 to 10.47 over the past decade. While the company's 10-year median is 4.72 vs. the industry median of 2.46, PT Prodia Widyahusada Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.46, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current 5-Year Yield-on-Cost % of 8.52 is 247% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current 5-Year Yield-on-Cost % is 8.52, which is 81% above median its own 10-year median of 4.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,133.50, compared to a current price of Rp2,390.00 — trading 23.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 8.52, which is 81% above median its 10-year median of 4.72 and 247% above the Medical Diagnostics & Research industry median of 2.46. PT Prodia Widyahusada Tbk's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current 5-Year Yield-on-Cost % is 8.52 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued.
The current stock price of Rp2,390.00 is trading 23.7% below its estimated GF Value™ of Rp3,133.50.
GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRDA:
5-Year Yield-on-Cost %: 8.52 (81% above median its 10-year median of 4.72)
GF Value™: Rp3,133.50 vs. price of Rp2,390.00 (23.7% below fair value)
Industry Position: 247% above the Medical Diagnostics & Research median (#12 of 64)
No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
69GF Score
Get the complete analysis for ISX:PRDA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRDA has been successfully added to your 
